MicroRNA-146a-3p/HDAC1/KLF5/IKBα signal axis modulates plaque formation of atherosclerosis mice

Huajin Liu1, Hongwei Wang1, Jiangwei Ma1

  • 1Department of Cardiology, Fengxian District Central Hospital, Shanghai, China.

Life Sciences
|May 18, 2021
PubMed
Abstract

Insights

MicroRNA-146a-3p (miR-146a-3p) depletion stabilizes atherosclerotic plaques by increasing histone deacetylase 1 (HDAC1) and inhibitors of kappa B alpha (IKBα) while decreasing Krüppel-like factor 5 (KLF5). This mechanism improves lipid profiles and reduces inflammation in atherosclerosis.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Immunology

Background:

  • Atherosclerosis (AS) is an immune-inflammatory disease driven by lipids affecting medium and large arteries.
  • Understanding the molecular mechanisms underlying AS plaque formation is crucial for developing effective treatments.

Purpose of the Study:

  • To elucidate the role of the microRNA-146a-3p (miR-146a-3p)/histone deacetylase 1 (HDAC1)/Krüppel-like factor 5 (KLF5)/inhibitors of kappa B alpha (IKBα) signaling axis in AS plaque development.
  • To investigate the therapeutic potential of targeting this axis in AS.

Main Methods:

  • Established an AS mouse model using ApoE-/- mice on a high-fat diet for 12 weeks.
  • Quantified expression of miR-146a-3p, KLF5, HDAC1, and IKBα in aortic tissues.
  • Verified the direct targeting of HDAC1 by miR-146a-3p.
  • Administered miR-146a-3p antagomir or HDAC1 overexpression in vivo and assessed effects on blood lipids, inflammatory factors, apoptosis, and plaque area.
  • Evaluated vascular endothelial cell (VEC) proliferation and apoptosis in vitro.

Main Results:

  • AS mice exhibited increased miR-146a-3p and KLF5, with decreased HDAC1 and IKBα in aortic tissues.
  • miR-146a-3p was confirmed to directly target HDAC1.
  • miR-146a-3p depletion or HDAC1 restoration lowered plasma lipids, reduced serum inflammatory factors, attenuated aortic apoptosis, enhanced antioxidant capacity, and improved plaque stability.
  • Downregulation of miR-146a-3p or upregulation of HDAC1 promoted VEC proliferation and inhibited apoptosis.

Conclusions:

  • Functional studies demonstrate that reduced miR-146a-3p enhances HDAC1 and IKBα expression while suppressing KLF5.
  • This modulation facilitates pathological plaque stability in atherosclerosis mouse models.
  • The miR-146a-3p/HDAC1/KLF5/IKBα axis represents a potential therapeutic target for AS.